The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
these patients require phenofibrates to bring down the vldl and triglyceride they respond to the to a lot of the standard LDL lowering therapies like Statin and acetamine they even respond to pcsk9 inhibition but sometimes we have to add on fibrates as well to maximally control them depends on how severe they are
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.